APA

Mandler R., Wu C., Sausville E. A., Roettinger A. J., Newman D. J., Ho D. K., King C. R., Yang D., Lippman M. E., Landolfi N. F., Dadachova E., Brechbiel M. W. & Waldmann T. A. (20001214). Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell lines. : Journal of the National Cancer Institute.

Chicago

Mandler R, Wu C, Sausville E A, Roettinger A J, Newman D J, Ho D K, King C R, Yang D, Lippman M E, Landolfi N F, Dadachova E, Brechbiel M W and Waldmann T A. 20001214. Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell lines. : Journal of the National Cancer Institute.

Harvard

Mandler R., Wu C., Sausville E. A., Roettinger A. J., Newman D. J., Ho D. K., King C. R., Yang D., Lippman M. E., Landolfi N. F., Dadachova E., Brechbiel M. W. and Waldmann T. A. (20001214). Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell lines. : Journal of the National Cancer Institute.

MLA

Mandler R, Wu C, Sausville E A, Roettinger A J, Newman D J, Ho D K, King C R, Yang D, Lippman M E, Landolfi N F, Dadachova E, Brechbiel M W and Waldmann T A. Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell lines. : Journal of the National Cancer Institute. 20001214.